This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For ThursdayBenzinga • 06/27/24
Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth StockZacks Investment Research • 06/24/24
Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific SessionsBusiness Wire • 06/21/24
Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the 2024 Annual European Hematology Association (EHA) CongressBusiness Wire • 06/14/24
Vertex Pharmaceuticals Incorporated (VRTX) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 06/11/24
Vertex Pharmaceuticals Incorporated (VRTX) The 44th Annual William Blair Growth Stock ConferenceSeeking Alpha • 06/07/24
Vertex Presents New Data at the European Cystic Fibrosis Conference Demonstrating Significant Benefits of Treatment with TRIKAFTA®Business Wire • 06/07/24
Why Vertex Pharmaceuticals (VRTX) is a Top Growth Stock for the Long-TermZacks Investment Research • 05/30/24
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?The Motley Fool • 05/30/24